期刊文献+

加味知柏地黄汤治疗甲状腺功能亢进性心脏病的临床效果 被引量:4

Clinical effect of modified Zhibai Dihuang decoction in the treatment of hyperthyroid heart disease
下载PDF
导出
摘要 目的研究加味知柏地黄汤治疗甲状腺功能亢进性心脏病的临床效果。方法将我院92例甲亢性心脏病患者随机分为试验组和对照组,各46例。对照组给予常规西药治疗,试验组在对照组的基础上给予加味知柏地黄汤治疗。分析两组患者的临床效果。结果试验组的治疗总有效率明显高于对照组(P<0.05);治疗后,两组患者的FT_3、FT_4水平、LVESD、LVEDD均低于治疗前,TSH水平、LVEF、E/A均高于治疗前,试验组均优于对照组(P<0.05)。结论甲亢性心脏病患者采用加味知柏地黄汤的临床治疗效果显著,可明显改善患者的甲状腺功能和心功能。 Objective To study the clinical effect of modified Zhibai Dihuang decoction in the treatment of hyperthyroid heart disease. Methods A total of 92 patients with hyperthyroid heart disease in our hospital were randomly divided into experimental group and control group, with 46 cases in each group. The control group accepted conventional western medicine treatment, and the experiment group was given modified Zhibai Dihuang decoction based on the control group.The clinical effects of the two groups were analyzed. Results The total effective rate of treatment in the experimental group was significantly higher than that in the control group(P〈0.05). After treatment, the levels of FT3, FT4, LVESD and LVEDD of the two groups were lower than those before treatment, the level of TSH, LVEF and E/A were higher than those before treatment, and those in the experimental group were better than the control group(P〈0.05). Conclusion Modified Zhibai Dihuang decoction in treatment of hyperthyroid heart disease has significant therapeutic effect, it can significantly improve thyroid function and cardiac function.
作者 传小文 黄雅静 CHUAN Xiao-wen;HUANG Ya-jing(Daxing Hospital of Xi'an,Xi'an 710016,China)
机构地区 西安大兴医院
出处 《临床医学研究与实践》 2018年第26期119-120,共2页 Clinical Research and Practice
关键词 加味知柏地黄汤 甲状腺功能亢进性心脏病 甲状腺功能 modified Zhibai Dihuang decoction hyperthyroid heart disease thyroid function
  • 相关文献

参考文献4

二级参考文献31

  • 1马德奎,肖辉骏,何先晓,黄辉.老年甲状腺机能亢进症的外科治疗[J].中国现代医学杂志,2005,15(1):107-109. 被引量:3
  • 2吴蔚,郑玲.甲状腺功能亢进性心脏病的心电图改变[J].海南医学,2005,16(7):18-18. 被引量:3
  • 3苏晓辉,刘守军,申红梅,张树彬,魏红联,于钧,叶永祥,李颖,刘颖,张志毅,孙殿军.2005年全国碘缺乏病监测资料汇总分析[J].中国地方病学杂志,2007,26(1):67-69. 被引量:53
  • 4中国甲状腺疾病诊治指南——甲状腺疾病的实验室及辅助检查[J].中华内科杂志,2007,46(8):697-702. 被引量:172
  • 5叶任高.内科学第5版[M].北京:人民卫生出版社,2002.471—479.
  • 6Siu CW, Zhang XH, Yung C,et al. Hemodynamic changes in hyperthyroidism-related pulmonary hypertension: a prospective echocardiographic study[J] .J Clin Endocr Metab, 2007, 92(5) :1736-1742.
  • 7Siu CW, Yeung CY, Lau CP, et al. Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism[J] .Heart, 2007,93(4) :483-487.
  • 8Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system[J] .N Engl J Med,2001,344(7) :501-509.
  • 9Franklyn JA. The management of hyperthyroidism[J] .N Engl J Med, 1994,330(24) :1731-1738.
  • 10Sabri O,Zinmy M,Schulz G,et al.Success rate of radioiodine therapy in Graves’ disease:the influence of thyrostatic medication[J] .J Clin Endocr Metab,1999,84(4) :1229-1233.

共引文献57

同被引文献52

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部